Skip to content

Author

O. Alsaidan

We have 4 of 162 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Comparative biomedical and photocatalytic efficacy of Malvastrum coromandelianum (L.) aqueous extract-assisted green synthesized zinc oxide and copper oxide nanoparticles.

This study presents the biogenic synthesis of CuO nanoparticles (NPs) and ZnO NPs using aqueous leaf extract of Malvastrum coromandelianum as a green reducing and stabilizing agent. The synthesized NPs were characterized by UV-vis, PXRD, FTIR, ZP, DLS, SEM, TEM, BET, and EDX. The photocatalytic potential of the synthes...

Shumaila Iqbal, Naveed Ahmad, A. Siddique et al. · 0 citations
Review Open access Aug 2026

Ethosomal drug delivery systems for skin cancer: Mechanistic insights, formulation strategies, and translational challenges

Introduction: Skin cancer is one of the most prevalent malignancies worldwide, with incidence increasing by approximately 2–3% annually due to prolonged ultraviolet radiation exposure, genetic predisposition, and an ageing population. Conventional treatments, including oral, injectable, and topical therapies, are often...

Bhupendra G. Prajapati, O. Alsaidan, Sami I. Alzarea et al. · 0 citations
Open access 2026

Protective Effects of Cubebin on Neuroinflammation, Neurotransmitter Depletion, Mitochondrial Dysfunction, and Motor Disability in Parkinsonian Rats

Parkinson’s disease (PD) is an advanced neurodegenerative state with diverse degeneration of dopaminergic neurons, oxidative stress, mitochondrial dysfunction, and neuroinflammation. The present study aimed to evaluate the neuroprotective effect of cubebin against rotenone-induced Parkinsonism disability in Wistar rats...

O. Alsaidan, Ameeduzzafar Zafar, Naveed Ahmad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.